Jason A. Hanna, Ph.D.
Jason A. Hanna, Ph.D.
Verified email at purdue.edu
Title
Cited by
Cited by
Year
Antibody validation
J Bordeaux, AW Welsh, S Agarwal, E Killiam, MT Baquero, JA Hanna, ...
Biotechniques 48 (3), 197-209, 2010
5972010
Proinvasion metastasis drivers in early-stage melanoma are oncogenes
KL Scott, C Nogueira, TP Heffernan, R van Doorn, S Dhakal, JA Hanna, ...
Cancer cell 20 (1), 92-103, 2011
1472011
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma
G Genovese, A Ergun, SA Shukla, B Campos, J Hanna, P Ghosh, ...
Cancer discovery 2 (8), 736-749, 2012
1142012
Stathmin expression and its relationship to microtubule‐associated protein tau and outcome in breast cancer
MT Baquero, JA Hanna, V Neumeister, H Cheng, AM Molinaro, LN Harris, ...
Cancer 118 (19), 4660-4669, 2012
662012
Quantitative analysis of microRNAs in tissue microarrays by in situ hybridization
JA Hanna, H Wimberly, S Kumar, F Slack, S Agarwal, DL Rimm
Biotechniques 52 (4), 235-245, 2012
662012
In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA
JA Hanna, L Hahn, S Agarwal, DL Rimm
Laboratory investigation 92 (10), 1390-1397, 2012
622012
Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from non-myogenic endothelial progenitors
CJ Drummond, JA Hanna, MR Garcia, DJ Devine, AJ Heyrana, ...
Cancer Cell 33 (1), 108-124. e5, 2018
372018
Quantitative assessment of miR34a as an independent prognostic marker in breast cancer
S Agarwal, J Hanna, ME Sherman, J Figueroa, DL Rimm
British journal of cancer 112 (1), 61-68, 2015
302015
The function, proteolytic processing, and histopathology of Met in cancer
JA Hanna, J Bordeaux, DL Rimm, S Agarwal
Advances in cancer research 103, 1-23, 2009
292009
PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma
JA Hanna, MR Garcia, A Lardennois, PJ Leavey, D Maglic, A Fagnan, ...
Oncogene 37 (15), 1991-2007, 2018
232018
PAX7 is a required target for microRNA-206-induced differentiation of fusion-negative rhabdomyosarcoma
JA Hanna, MR Garcia, JC Go, D Finkelstein, K Kodali, V Pagala, X Wang, ...
Cell death & disease 7 (6), e2256-e2256, 2016
172016
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. Cancer Discov. 2012; 2: 736–749. doi: 10.1158/2159-8290
G Genovese, A Ergun, SA Shukla, B Campos, J Hanna, P Ghosh, ...
PloS One 10, e0120905, 2015
162015
Biallelic Dicer1 loss mediated by aP2-Cre drives angiosarcoma
JA Hanna, CJ Drummond, MR Garcia, JC Go, D Finkelstein, JE Rehg, ...
Cancer research 77 (22), 6109-6118, 2017
62017
GENO-21 BRCA1 protein expression predicts survival in glioblastoma patients from a NRG Oncology/RTOG cohort
M Vassilakopoulou, M Won, W Curran, L Souhami, M Prados, C Langer, ...
Neuro-oncology 17 (suppl_5), v96-v96, 2015
22015
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort
M Vassilakopoulou, M Won, WJ Curran, L Souhami, MD Prados, ...
Oncology, 1-9, 2021
2021
Modeling the vascular sarcoma spectrum with genetically engineered mice
JA Hanna, CG Langdon, MR Garcia, D Finkelstein, JE Rehg, ME Hatley
Cancer Research 79 (13 Supplement), 4631-4631, 2019
2019
Abstract PR12: Hedgehog pathway drives fusion-negative rhabdomyosarcoma initiated from nonmyogenic endothelial progenitors
CJ Drummond, JA Hanna, MR Garcia, DJ Devine, AJ Heyrana, ...
Cancer Research 78 (19 Supplement), PR12-PR12, 2018
2018
Location specificity in fusion-negative rhabdomyosarcoma driven by cell of origin
CJ Drummond, JA Hanna, MR Garcia, DJ Devine, AJ Heyrana, ...
Cancer Research 78 (13 Supplement), 3014-3014, 2018
2018
Abstract A31: Biallelic Dicer1 loss in endothelial cells drives angiosarcoma development
JA Hanna, CJ Drummond, MR Garcia, JC Go, D Finkelstein, JE Rehg, ...
Cancer Research 78 (10 Supplement), A31-A31, 2018
2018
Biallelic Dicer1 loss in endothelial cells drives angiosarcoma development.
JA Hanna, CJ Drummond, MR Garcia, JC Go, D Finkelstein, JE Rehg, ...
CANCER RESEARCH 78 (10), 46-46, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20